• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Some monoclonal antibody treatments still available in Arkansas despite FDA's limit

Emily

Editor, Senior Moderator
https://www.5newsonline.com/article/...9-56b45933d47b
Some monoclonal antibody treatments still available in Arkansas despite FDA's limit
Throughout the pandemic, monoclonal antibody treatments have proven to be effective against COVID-19. Now, the FDA said they are limited two treatments.
Author: Frederick Price (KTHV)
Published: 6:36 PM CST January 27, 2022
Updated: 6:56 PM CST January 27, 2022

LITTLE ROCK, Ark. — "Almost 100% of the circulating viruses here in the U.S. is suspected to Omicron," said Dr. Naveen Patil, deputy state health officer for the Arkansas Department of Health.
...

One of the medicines Dare said UAMS is using for mild cases is Sotrovimab.

"It works on Omicron, just as well as it worked on Delta, just as well as it worked on alpha and the other variants," Dare said.

Those treatments are usually given in the hospital's COVID infusion center.

They see nearly 20 outpatients daily.

"When we have monoclonal available, we pretty much max that out every single day," Dare said.

Patil said the state is seeing a supply shortage in other drugs, such as Paxlovid.

That is proven to treat mild cases as well, if taken within a few days after infection.
 
Back
Top